Cargando…

Corrigendum to “From Cryptic Toward Canonical Pre-mRNA Splicing in Pompe Disease: a Pipeline for the Development of Antisense Oligonucleotides”

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155320/ https://www.ncbi.nlm.nih.gov/pubmed/27898093 http://dx.doi.org/10.1038/mtna.2016.104

Ejemplares similares

From Cryptic Toward Canonical Pre-mRNA Splicing in Pompe Disease: a Pipeline for the Development of Antisense Oligonucleotides
por: Bergsma, Atze J, et al.
Publicado: (2016)

Induction of cryptic pre-mRNA splice-switching by antisense oligonucleotides
por: Ham, Kristin A., et al.
Publicado: (2021)

Corrigendum to “Presymptomatic Treatment with Acetylcholinesterase Antisense Oligonucleotides Prolongs Survival in ALS (G93A-SOD1) Mice”
por: Gotkine, Marc, et al.
Publicado: (2015)

Non-canonical translation initiation of the spliced mRNA encoding the human T-cell leukemia virus type 1 basic leucine zipper protein
por: Cáceres, C Joaquín, et al.
Publicado: (2019)

Mathematical modeling identifies potential gene structure determinants of co-transcriptional control of alternative pre-mRNA splicing
por: Davis-Turak, Jeremy, et al.
Publicado: (2019)

Antisense oligonucleotide-induced alternative splicing of the APOB mRNA generates a novel isoform of APOB
por: Khoo, Bernard, et al.
Publicado: (2007)

Antisense Oligonucleotides Promote Exon Inclusion and Correct the Common c.-32-13T>G GAA Splicing Variant in Pompe Disease
por: van der Wal, Erik, et al.
Publicado: (2017)

Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotides
por: Wang, Zhenxun, et al.
Publicado: (2012)

Selective targeting of MYC mRNA by stabilized antisense oligonucleotides
por: Gill, Taylor, et al.
Publicado: (2021)

Splice-switching antisense oligonucleotides as therapeutic drugs
por: Havens, Mallory A., et al.
Publicado: (2016)

Corrigendum to “Assessment of toxicity and biodistribution of recombinant AAV8 vector–mediated immunomodulatory gene therapy in mice with Pompe disease”
por: Wang, Gensheng, et al.
Publicado: (2015)

Antisense Oligonucleotide Induction of the hnRNPA1b Isoform Affects Pre-mRNA Splicing of SMN2 in SMA Type I Fibroblasts
por: Toosaranont, Jarichad, et al.
Publicado: (2022)

Delivery of antisense oligonucleotides for splice‐correction of androgen receptor pre‐mRNA in castration‐resistant prostate cancer models using cell‐penetrating peptides
por: Luna Velez, Maria V., et al.
Publicado: (2022)

Splice modulating antisense oligonucleotides restore some acid-alpha-glucosidase activity in cells derived from patients with late-onset Pompe disease
por: Aung-Htut, May Thandar, et al.
Publicado: (2020)

The Role of Canonical and Noncanonical Pre-mRNA Splicing in Plant Stress Responses
por: Dubrovina, A. S., et al.
Publicado: (2013)

Antisense-oligonucleotide-directed inhibition of nonsense-mediated mRNA decay
por: Nomakuchi, Tomoki T., et al.
Publicado: (2015)

Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides
por: Aung-Htut, May T., et al.
Publicado: (2019)

Corrigendum to “Cyclin G2 Suppresses Glomerulosclerosis by Regulating Canonical Wnt Signalling”
por: Zhao, Chenyang, et al.
Publicado: (2019)

Dynamics of Co-Transcriptional Pre-mRNA Folding Influences the Induction of Dystrophin Exon Skipping by Antisense Oligonucleotides
por: Wee, Keng Boon, et al.
Publicado: (2008)

Antisense Oligonucleotide- and CRISPR-Cas9-Mediated Rescue of mRNA Splicing for a Deep Intronic CLRN1 Mutation
por: Panagiotopoulos, Anna-Lena, et al.
Publicado: (2020)

Selection of antisense oligonucleotides based on multiple predicted target mRNA structures
por: Bo, Xiaochen, et al.
Publicado: (2006)

Corrigendum to: A quantitative systems pharmacology approach to support mRNA vaccine development and optimization
Publicado: (2022)

Corrigendum to “Risk Assessment of Fishing Trawl Activities to Subsea Pipelines of Sabah and Labuan Waters”
por: Fuad, Ahmad Faizal Ahmad, et al.
Publicado: (2020)

Targeting a pre-mRNA structure with bipartite antisense molecules modulates tau alternative splicing
por: Peacey, Eleanor, et al.
Publicado: (2012)

An Antisense Oligonucleotide against a Splicing Enhancer Sequence within Exon 1 of the MSTN Gene Inhibits Pre-mRNA Maturation to Act as a Novel Myostatin Inhibitor
por: Maeta, Kazuhiro, et al.
Publicado: (2022)

Small antisense oligonucleotides against G-quadruplexes: specific mRNA translational switches
por: Rouleau, Samuel G., et al.
Publicado: (2015)

mRNA levels can be reduced by antisense oligonucleotides via no-go decay pathway
por: Liang, Xue-hai, et al.
Publicado: (2019)

Antisense oligonucleotides for Alzheimer's disease therapy: from the mRNA to miRNA paradigm
por: Grabowska-Pyrzewicz, Wioleta, et al.
Publicado: (2021)

Hybridization-mediated off-target effects of splice-switching antisense oligonucleotides
por: Scharner, Juergen, et al.
Publicado: (2020)

[Corrigendum] METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression
por: Zhang, Yongxi, et al.
Publicado: (2023)

Antisense Oligonucleotide-mediated Suppression of Muscle Glycogen Synthase 1 Synthesis as an Approach for Substrate Reduction Therapy of Pompe Disease
por: Clayton, Nicholas P, et al.
Publicado: (2014)

Corrigendum to “Inhibition of enterovirus 71 infection by antisense octaguanidinium dendrimer-conjugated morpholino oligomers” [Antiviral Res. 107 (2014) 35–41]
por: Tan, Chee Wah, et al.
Publicado: (2014)

Corrigendum to: Integrating Omics and Alternative Splicing Reveals Insights into Grape Response to High Temperature
por: Jiang, Jianfu, et al.
Publicado: (2022)

Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides
por: Anderson, Brooke A, et al.
Publicado: (2021)

Improving attitudes toward electroconvulsive therapy – CORRIGENDUM
por: Cheung, Oakley, et al.
Publicado: (2022)

Pan-cancer repository of validated natural and cryptic mRNA splicing mutations
por: Shirley, Ben C., et al.
Publicado: (2019)

Antisense oligonucleotides correct the familial dysautonomia splicing defect in IKBKAP transgenic mice
por: Sinha, Rahul, et al.
Publicado: (2018)

Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression
por: Lim, Kian Huat, et al.
Publicado: (2020)

Reduction of integrin alpha 4 activity through splice modulating antisense oligonucleotides
por: Aung-Htut, May T., et al.
Publicado: (2019)

Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation
por: Raguraman, Prithi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dkkjtn7i8k79vpl63t4op7l8do